Daniela Lenggenhager

7PUBLICATIONS
62CO-AUTHORS
Major global burdens of diseasePredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Haematological tumoursAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 13, 2024
HEV ORF2 protein-antibody complex deposits are associated with glomerulonephritis in hepatitis E with reduced immune status.

Anne-Laure Leblond, Birgit Helmchen, Maliki Ankavay

|Oct 02, 2024
Molecular and functional landscape of malignant serous effusions for precision oncology.

Rebekka Wegmann, Lorenz Bankel, Yasmin Festl

|Apr 04, 2024
Identification of tumour regression in neoadjuvantly treated pancreatic cancer is based on divergent and nonspecific criteria.

Maia Blomhoff Holm, Daniela Lenggenhager, Sönke Detlefsen

|Jan 27, 2022
De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancer.

Sabrina Steiner, Gitta M Seleznik, Theresia Reding

|Mar 25, 2021
NASH limits anti-tumour surveillance in immunotherapy-treated HCC.

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol

Pageof 2